Incidence of Bleeding on Probing as an Indicator of Peri-Implant Disease Progression

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-09-11

Study Completion Date

2027-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary goal of the present prospective cohort study is to evaluate the effect of varying incidences of BOP at implant sites across 15 months of maintenance visits on the probability of peri-implant disease progression. Over 15 months, participants will attend 6 visits where clinical measurements and maintenance care will be performed every 3 months.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Experimental Peri-implant Mucositis on Implant Sites That Were Previously Treated With or Without Implantoplasty

NCT06063876

Peri-implant Mucositis Peri-Implantitis

ENROLLING_BY_INVITATION NA

Long-term Outcomes of Implants in Patients with Periodontitis

NCT06852599

Peri-Implant Health Periodontitis Peri-implant Mucositis +1 more

COMPLETED

Prospective Longitudinal Clinical Study for the Evaluation of Peri-implant Tissue and Osseointegration After Rehabilitation With Osseointegrated Implants

NCT06967649

Osseointegration Failure of Dental Implant Periimplantitis Peri-Implant Tissues +6 more

ENROLLING_BY_INVITATION NA

Incidence of Peri-implant Mucositis in Patients With Treated Periodontitis

NCT05356806

Peri-implant Mucositis

RECRUITING

The Influence of Implant Position on the Occurrence of Biological Complications

NCT05358782

Peri-Implantitis

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Screening/Baseline/Maintenance Visit 1 (V1) After participants have consented, their health history will be reviewed, and their vitals including blood pressure and heart rate will be recorded. A dental exam of the teeth and gums will be completed. During this exam, a UNC 15 periodontal probe will be used to perform the clinical assessments. Intraoral photographs will be taken. An x-ray of the implant(s) included in the study will be taken using a customized x-ray holder (created during Visit 1) so that at the end of the study, a final x-ray will be taken in the exact same position. Finally, each participant will receive a dental prophylaxis (D1110) or maintenance (D4910) according to their prior periodontal diagnosis.

Maintenance Visits 2-6 (V2-V6) Participants will return in 3-month intervals at approximately 3, 6, 9, 12, and 15 months (+/- 10 days) for Study Visits V2 - V6. At each of these visits, individuals will be asked about continued participation in the study. Participants will also be asked if there have been any changes to medical or dental history and if they are taking any new medications. Intraoral photographs of the study area will be performed, as well as, collecting measurements from around the dental implant(s), and providing regular dental cleaning. At the 15 month visit, a final x-ray will be taken using the custom x-ray holder made at the first visit.

Clinical and radiographic assessments will include:

1. BOP: at each of the 4 measured locations surrounding the implant of interest will be recorded as follows:

1. Score 0 - No BOP
2. Score 1 - Bleeding dot
3. Score 2 - Continuous line of blood that fills the sulcus
4. Score 3 - Profuse bleeding and/or hemorrhage drip.
2. Probing depths (PD): at 4 locations surrounding the implant of interest (mesiolingual (ML), mesiobuccal (MB), distolingual (DL), and distobuccal (DB)). PD increase must exceed a threshold of 0.8mm to be considered progression.
3. Recession: measured at each of the 4 locations surrounding the implant of interest.
4. Keratinized mucosa width: measured at the midbuccal aspect of the implant(s).
5. Mucosal thickness: assessed with the aid of an endodontic spreader, 2mm below the mucosal margin, at the midbuccal aspect of the implant(s).
6. Marginal bone loss (MBL): measured by overlaying the baseline and final radiographs and measuring the change in marginal bone levels. Progression will have to exceed a threshold of 0.5mm to be considered.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Peri-Implantitis Bleeding of Subgingival Space

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Dental prophylaxis or maintenance will be performed every 3 months.

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adults in good general health (at least ASA 2)
* having ≥ 1 dental implant that was restored before January 2021
* patients of the University of Pittsburgh Periodontics Department
* available for maintenance visits every 3 months for the length of the study

Exclusion Criteria

* Active infectious diseases of any kind
* Pregnant or planning to become pregnant (self-reported)
* Congenital or metabolic bone disorders
* Current heavy smokers: Subjects who have smoked more than 1 pack/day within 6 months of study onset
* Co-morbid conditions that would affect the study outcome or interpretation of study results
* Require treatment for periodontal disease prior to baseline

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes